Replies to post #331994 on Amarin Corp Plc (AMRN)

[postes]

We've got to get the analysts on board that we can sell in Europe.

If they are successful in Germany analysts will get on board...AMRN is in prove it first mode.

[hayward]

studythosestocks

Inserting FFS is calling for $10 the day of official approval. So far your call of below $6 .10 cents from today's close is a hell of a lot closer then plus 3.90 to get to $10.

Michael

[money_man]

The message to shareholders following formal approval will be telling. Until now, JT was able to remain vague on EU strategy, as anything more would have been speculative and conditional on approval. Now that we have EMA approval, it is time for JT to provide guidance as well as outlay a detailed plan for maximizing and growing shareholder value. A CC is absolutely essential and anything less would be completely crazy given the magnitude of EU for this company.

If, however, JT mumbles and bumbles his way through another drab CC, remaining committed to vague GIA strategy...oof look out. PPS would likely not respond favorably (which perhaps would be the ideal prelude to a BO...why else would JT remain vague at this critical stage??).

[alm2]

Study - Europe sales
Amarin is currently selling 80k approx in USA - see weekly script figures
Can Europe relatively quickly not provide another 20k per week taking Amarin over 100k ? Would that growth (and more) impress the market ?

Growth is now possible into a whole new market no generic competition - no advertising costs
Tying up supply with Amarin

Big pharma seeing it working in practice can only help tempt them further
China ROW - USA not the dead duck it was once thought?

Lots of positives to consider

It’s a big market world wide that is suddenly opening up ...

Does not seem much basis to run the share price down ???
Alm